Photo by Chokniti Khongchum from Pexels

Few healthcare companies were included in the annual ranking of innovative companies from the analytics firm Clarivate plc (NYSE:CLVT).

Two companies in pharma and another in medtech, however, made the cut.

Johnson & Johnson was featured for the second consecutive year as a top 100 Global innovator.

Roche was included for the 11th consecutive year in the report.

In medtech, Philips was included for the second consecutive year.

Clarivate notes the fragmented nature of pharmaceutical research contributes to the limited number of companies in the ranking. Given the elevated role of academia and contract firms in drug discovery and development, it is more challenging for any single entity to stand out in the industry.

Additionally, Clarivate concluded that the ability of the pharmaceutical sector to innovate has fallen since last year. The firm projects that the level of innovation in the industry will continue to fall to 2023 and will then plateau until 2025.

Within the pharmaceutical industry, Clarivate cited the following companies as the most innovative:

Top 20, Pharmaceuticals   Region Country
Abbott Americas US
Abbvie Americas US
Amgen Americas US
AstraZeneca EMEA UK
Bayer EMEA Germany
Boehringer Ingelheim EMEA Germany
Bristol Myers Squibb Americas US
Eisai APAC Japan
Gilead Sciences Americas US
GlaxoSmithKline EMEA UK
Johnson & Johnson Americas US
Lilly Americas US
Merck Sharp & Dohme Americas US
Novartis EMEA Switzerland
Novo Nordisk EMEA Denmark
Otsuka Pharmaceutical APAC Japan
Pfizer Americas US
Roche EMEA Switzerland
Sanofi EMEA France
Takeda Americas Japan